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A potential role for glycolipid gangliosides to act as immunomodulating agents has been
suggested. Most studies have employed brain gangliosides. We have systematically investigated
highly purified murine brain gangliosides for their ability to modulate lymphocyte activation. All
sialic acid classes of ganglioside inhibited lipopolysaccharide (LPS)-induced antibody secretion
and all polysialated gangliosides inhibited LPS-induced DNA synthesis. Monosialated ganglio-
sides had no effect on DNA synthesis induced by LPS. 8-BrcGMP-induced DNA synthesis was
also inhibited, suggesting that a negative signal was delivered to B lymphocytes by co-cultivation
with exogenous gangliosides. The lack of specificity with respect to sialic acid class observed in
these studies suggests that further investigation of an immunomodulatory role for gangliosides
focus on endogenous lymphocyte gangliosides.
INTRODUCTION
Gangliosides are amphipathic glycosphingolipids containing sialic acid and an
oligosaccharide chain which is bonded to ceramide. The hydrophobic ceramide
anchors the molecule in the plasma membrane lipid bilayer, while the oligosaccharide-
sialic acid is exposed to the external environment. The physiologic role ofthese plasma
membrane glycolipids has been the subject ofintense study which has focused on their
role in neuronal events, since gangliosides are present in high concentrations in
neuronal tissue [1]. In peripheral tissues, gangliosides appear to act as receptors, or as
a component of a receptor complex, for a variety ofligands, including bacterial toxins
[2,3], polypeptide hormones [4], fibronectin [5], interferon [6], and lymphokines [7].
They also have an important role in cellular growth processes, including contact
inhibition [8]. It has been postulated recently that gangliosides may mediate the
transmembrane events which occur during lymphocyte activation [9]. The pattern of
gangliosides in lymphocytes is characteristic for cellular types and subtypes and may
be related to the functional capacity ofcells [10].
In this investigation, the ability of murine brain gangliosides to modulate lympho-
cyte responsiveness to activating agents has been assessed. Our earlier studies showed
that certain bovine brain gangliosides inhibited murine B lymphocyte stimulation by
bacterial lipopolysaccharide (LPS) and had little effect on phytohemagglutinin
(PHA) activation of T lymphocytes [11]. More recent studies have shown that
leukemia cell gangliosides exert a similar inhibitory influence on human lymphocyte
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activation [12]. Other investigators have shown that specific gangliosides may exert
profound effects on lymphocyte activation by lectins [13] and by antigens [14,15]. It
has also been demonstrated that the expression ofexogenous gangliosides and modified
gangliosides on lymphocytes allows new immunologic reactivity to emerge [16,17]. In
spite of these studies a clear understanding of the role of gangliosides in lymphocyte
activation has notemerged. We now show that all sialicacid classes ofexogenous brain
gangliosides are able to modulate lymphocyte activation. Various possibilities for the
inhibitory effects observed are discussed.
MATERIALS AND METHODS
Mice
Balb/c and C3H/HeN mice were obtained from the NIH breeding colony,
Bethesda, MD. C3H/HeJ arid C3Heb/FeJ mice were obtained from Jackson Labora-
tories, Bar Harbor, ME. All thice were female, 6-18 weeks old when used.
Cell Cultures
Splenic lymphocytes wete obtained and cultured as previously described [18].
Eagles minimal essential miedium (MEM) supplemented with 1 mM glutamine,
5 x 10-5M 2-mercaptoethanol, 25 U/ml penicillin, 25 ,ug/ml streptomycin, 25 ,ug/ml
gentamicin, 1 mM pyruvate, and 1 percent non-essential amino acids (NEAA) was
used in the antibody secretion experiments. The same medium without pyruvate and
NEAA was used for mitogenesis assays. Antibody secretion was measured using a
modification of the Jerne plaque assay [19]. Data is presented as the number of
plaque-forming cells (PFC) per 106 viable cells recovered on the day of assay.
Lymphocytes were cultivated in one ml ofmedium (106 cells/ml) in Linbro plates.
Mitogenesis was measured by pulsing 0.2 ml cell cultures (5 x I05 cells/well) with 1
uCi of 3HTdR for the final twenty-four hours of a seventy-two hour culture period
[18].
Lymphocyte Activators
E. coli K235 lipopolysaccharide, prepared by phenol extraction [20] and butanol
extraction [21], was kindly supplied by Dr. David C. Morrison, Emory University.
Other LPS preparations and 8 BrcGMP were obtained from Sigma Chemical Co., St.
Louis, MO.
Gangliosides
Mouse brain gangliosides were prepared using a modification ofpublished methods
[22]. Briefly, brain was homogenized and extracted with chloroform-methanol (1:2,
v/v). The extract was filtered, applied to a DEAE Sephadex A-25 column, washed
thoroughly toremove neutral lipids, and eluted with0.1 M sodiumacetate in methanol.
The eluant was saponified with 0.1 M sodium hydroxide to destroy phospholipid; then
it was dialyzed, lyophilized, atid resuspended in chloroform-methanol (95:5, v/v) for
further purification by chromatography on porous silica beads (Iatron Laboratories,
Tokyo, Japan). The purified ganglioside fraction was obtained using a stepwise
chloroform-methanol gradient. Sialic acid classes were separated by fractionation on
DEAESephadexA-25, using a methanol-ammonium acetategradient forelution [23].
Subclasses of sialic acid groups (i.e., individual gangliosides) were separated by
latrobead chromatography using a gradient ofchloroform-methanol-water for elution
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FIG. 1. Effect ofbraingangliosides on LPS-
0 induced DNA synthesis. Spleen cells from
Balb/c mice were incubated in the presence of
LPS (Salmonella minnesota R595, 10 Ag/ml)
and individual brain gangliosides (10 ,g/ml).
The open bars represent the mean cpm ± SD
for triplicate cultures containing both LPS and
ganglioside. The hatched bars show similar
COnird GM GDX GD, GTIb data for cultures without added LPS.
[22]. Gangliosides (1.0 mg/ml) were stored in chloroform-methanol (1:1, v/v) at
-200C. Sialic acid was determined by the resorcinol method [24].
Asialoganglioside (ASG) was prepared by treating brain mixed trisialoganglioside
(GT ganglioside) for one hour at 800C with 0.1 N HCl. An oligomer of sialic acid
(NANA)5 was the kind gift ofStefan Svenson, Stockholm, Sweden.
Statistical Analysis
Students t test (unpaired, two-tailed) was used to test for statistical significance
(p < 0.05).
RESULTS
Inhibition ofLPS-Induced Mitogenesis by Gangliosides
Isolated, purified murine brain gangliosides were investigated for their ability to
modulate LPS-induced DNA synthesis in lymphocytes. The trisialoganglioside, GTIb
(IV3 NeuAc, II3 (Neu Ac)2-GgOse4Cer), was the most effective inhibitor of the four
ganglioside preparations tested (Fig. 1). No inhibition was observed with the monosia-
loganglioside preparation. It appeared that more highly sialated gangliosides were
more effective inhibitors. Considerable variation between experiments in the amount
of inhibition observed was seen with a given concentration of ganglioside (50-95
percent for trisialogangliosides at 10 ltg/ml) but the pattern ofinhibition by individual
gangliosides was consistent. The modest amount of inhibition of baseline thymidine
uptake which was observed with GDIb (II3 (NeuAc)2-GgOse4Cer) and GTIb (hatched
bars) was felt to represent nonspecific toxicity of the gangliosides. This question of
ganglioside-induced toxicity was investigated further byassessing lymphocyteviability
after 72 hours of culture with LPS and gangliosides (Table 1). Minimal toxicity was
evident at 10 ,tg/ml ganglioside, but a definite loss of cells (20-25 percent) was
observed at 50 ,ug/ml.
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TABLE 1
Viability in the Presence of Ganglioside and LPS'
% Viable
10,g/ml Ganglioside 50,ug/ml Ganglioside
Ganglioside Control LPS Control LPS
Control 43 48 43 48
GM 37 39 39 28
GDIa 39 43 34 30
GT 38 37 24 27
aC3H/HeJ spleen cells (5 x 105cells/well) were incubated in Eagles MEM without
serum for 72 hours with gangliosides and LPS (butanol E. coli K235, 10 ,g/ml) in
flat-bottom microtiter plates. Eachvalue represents the percentage ofcells that were
viable as assessed by trypan blue exclusion. This isa representative experiment from
three separate experiments. At least 200 cells were counted to determine each
point.
Role ofSialic Acid in Ganglioside Inhibition ofLymphocyte Activation
The importance ofsialic acid groups in mediating the inhibition oflymphocytes by
gangliosides was investigated by preparing asialoganglioside from GT and comparing
its ability to inhibit mitogenesis with the intact ganglioside (Fig. 2). ASG had no effect
on LPS-induced mitogenesis while the parent GT was a dose-dependent inhibitor. Free
sialic acid also had no inhibitory effect at 100 ,g/ml (10,316 ± 526 cpm vs. 13,336 ±
2,655 cpm). An oligomerofsialic acid, however, possessed inhibitory activity though it
was not as potent as intact ganglioside (Table 2). These data suggest that the presence






FIG. 2. Lackofeffect ofasialoganglioside in inhib-
iting LPS-induced DNA synthesis. Spleen cells from
C3Heb/FeJ mice were incubated for three days with
LPS (E. coli 0111 :B4, Westphal, 10 jtg/ml): either
alone, black bar; with asialoganglioside, open bars; or
I L |_ _5 with GT, hatched bars. Each value represents the
0 5 I0 25 mean cpm ± SD for thymidine uptake of triplicate
Ganglioside (,ug/ml) culture wells.
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TABLE 2
Effect of Sialic Acid Oligomer on the Inhibition of LPS-Induced Mitogenesis
cpm/Culture'
LPS (Mg/ml)' Control GDlab (NANA)3
0 644± 167 556± 11 317±30
10 23,807 ± 1,370 2,353 ± 1,227 7,843 ± 1,041
25 23,364 ± 2,065 1,667 ± 1,035 8,286 ± 1,169
'Each value represents the cpm ± SD from triplicate culture wells of C3Heb/FeJ spleen cells (5 x i0'
cells/well). Experiments were repeated at least twice, and a representative experiment is shown.
bLPS from E. coli K235 (phenol-extracted) was employed. GD1a was used at 50 ug/ml. The oligomer of
NANA was used at 38 Ag/ml, which represents an equimolar amount.
Ganglioside Modulation ofAntibody Secretion
In order to assess whether the inhibitory effect of gangliosides on LPS activation
extended to other lymphocyte functions, we investigated the ability ofeach sialic acid
class of ganglioside to modulate polyclonal antibody synthesis induced by LPS. In
these experiments the number of PFC reported is per 106 viable cells recovered at the
time of assay. This was done to eliminate all nonspecific toxic effects of the
gangliosides during the four-day culture period. All sialic acid classes of ganglioside
inhibited the generation ofPFC by LPS (Table 3). As with mitogenesis, this inhibition
was not observed with asialoganglioside.
Potential Mechanismfor Ganglioside Inhibition
One attractive hypothesis is that the interaction of gangliosides with the B
lymphocyte renders it unresponsive to LPS. To investigate this directly, spleen cells
were preincubated with GTIb, washed, and stimulated with LPS. No inhibition of
LPS-induced DNA synthesis was observed. After a one-hour exposure toGTIb, spleen
TABLE 3
Ganglioside Modulation of the Polyclonal Antibody Response to LPS'
PFC/106 Cellsb
Gangliosidec LPS LPS/Ganglioside
GM, 413 ± 59 246 ± 50
GDla 429 ± 90 93 ± 10
GDlb 274 ± 19 104 ± 58
GTIb 372 ± 110 190 ± 13
ASG 321 ± 9 374 ± 82
aE. coli K235 LPS (phenol-extracted), 10,g/ml was used in all experiments. The
number of IgM PFC to sheep red blood cells (SRBC) was assessed on day 4 of
culture ofC3H/HeN spleen cells (106 cells/well).
bExperiments were repeated on different days so independent controls were always
done for each ganglioside. Each value represents the mean ± 2 standard error of
mean (SEM) for the PFC/10' cells of duplicate cultures from representative
experiments. Each experiment was repeated at least twice.
C50 ,ug/ml ofganglioside was added to each culture on day 0. PFC were related to




Effect of Preincubation with Gangliosidea on Lymphocyte Mitogenesis
cpmb
LPS (,ug) Control Preincubated
0 696 ± 62 556 ± 50
1 2,054 ± 42 2,243 ± 242
10 7,118 ± 308 8,841 ± 425
50 9,956 ± 305 11,968 ± 255
aBalb/c spleen cells (106 cells/ml) were preincubated with 50Mg/ml ofGTIb for one
hour, washed in BSS, and cultured with E. coli K235 LPS (phenol-extracted) for
three days.
bEach value represents the mean ± SD for triplicate cultures which were preincu-
bated with medium (control) or ganglioside (preincubated). There is no statistical
difference between any ofthe paired values.
cells were fully stimulable by LPS (Table 4). The same result was obtained after a
four-hour exposure ofspleen cells toGTIb. Thus binding ofGTIb does not appear to be a
sufficient signal to inhibit the lymphocyte response to LPS. In a separate set of
experiments, uptake ofGTib into thymocytes was assessed. After exposure toGTib at 50
,ug/ml, thymocyte gangliosides were extracted and displayed by thin layer chromatog-
raphy. GTlb was easily seen in these chromatograms even when too few cells (3 x 107)
were used to visualize endogenous thymocyte gangliosides. Similar results were
obtained when the cells were left in culture for 72 hours after exposure to the
ganglioside. 1-2 ,ug of ganglioside sialic acid was bound per 8 x 107 cells after
washing.
We also tested the ability ofgangliosides to inhibit B lymphocyte activation induced
by a structurally independent lymphocyte activator. 8 BrcGMP has been shown to be a
potent mitogen for B lymphocytes [24]. GD1a (IV3 NeuAc, II3NeuAc-GgOse4Cer) was
found to be a potent inhibitor of 8 BrcGMP-induced lymphocyte activation (Fig. 3).
Thus the inhibitory effects of ganglioside were observed both with LPS-induced
activation and 8 BrcGMP-induced activation oflymphocytes.
DISCUSSION
Exogenous gangliosides have been known to induce changes in the functional
properties of lymphocytes for nearly a decade [10]. The mechanisms by which these
alterations are produced remain obscure. Oneofthe most attractive possibilities is that
alterations in the ganglioside composition of the plasma membrane renders the cell
incapable of receiving or responding to an activating signal [25]. This might occur
because theganglioside modifies the fluidity ofthe membrane [8] or because it induces
a second signal within the cell such that the lymphocyte does not respond to LPS.
There is evidence in other systems that gangliosides induce increases in cyclic AMP
through an activation of adenyl cyclase [26]. Such changes have not been demon-
strated in lymphocytes. It has also been suggested that exogenous gangliosides may
associate with endogenous membrane gangliosides which are critical components of a
receptor complex [9]. This could inhibit the cross-linking of receptors and the
transmembrane signal required for triggering the cell. Our data are totally consistent
with this hypothesis.
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0
Eb 44 ;:FIG. 3. Effect of disialoganglioside on 8
0 BrcGMP-inducedDNA synthesis.Spleencells
from C3Heb/FeJ mice were incubated for
three days with 8 BrcGMP in the absence
(open bars) and presence (hatched bars) of
ganglioside. The disialoganglioside, GDb (10
Mg/ml) was used in this experiment. Similar
data were obtained with trisialogangliosides.
0 0.25 0.50 1.0 2.0 Each value represents the mean cpm ± SD of
8-BrcGMP (mM) thymidine uptake in triplicate cultures.
Another mechanism which might explain the inhibitory effects of ganglioside in
these experiments is a direct interaction between the ganglioside and LPS. In other
studies we have demonstrated that stable molecular complexes between ganglioside
and LPS are produced by co-cultivation [27]. It is unlikely that this phenomenon can
fully explain the observed data since there was equally potent inhibition of both LPS
and 8 BrcGMP. In addition, others have found thatganglioside blocks lectin-mediated
activation of cells without influencing the binding of the lectin [13]. The situation is
more complex with LPS since binding of LPS to lymphocytes is nonspecific and not
clearly associated with physiologic responses [28,29].
All sialic acid classes of ganglioside have an inhibitory effect on LPS activation of
murine lymphocytes. It is clear that the presence of sialic acid is necessary for
inhibitory activity and that more highly sialated gangliosides appear to have increased
inhibitory activity. The lack of sialic acid specificity of the brain gangliosides used in
inhibiting LPS activation of lymphocytes argues against a role for these brain
gangliosides as receptors for endotoxins. Specific gangliosides have been shown to be
receptors for other bacterial toxins, although the specificity is not absolute [30].
Binding of gangliosides to the lymphocyte surface does not appear to be a sufficient
perturbation to alter LPS activation since these data show that G.nb binds to cells
rapidly, but that it has noinhibitory effect even after a four-hour incubation. It appears
that the continued presence ofganglioside is required to manifest inhibition.
Recent investigations have demonstrated that the composition oflymphoid ganglio-
sides is profoundly different from brain gangliosides [31]. There are significant
differences in the ganglioside composition of lymphoid cells between various species.
Lymphoid gangliosides are often rich in the monosialated class, particularly GM3
[32,33,34,35]. Some disialated compounds are present in lower concentrations, but no
higher order gangliosides have been demonstrated [32]. Additionally, the sialic acid
moiety of non-neural gangliosides is different from brain gangliosides with N-
glycoyl-neuraminic acid often predominating over N-acetyl neuraminic acid
(NANA). Thus it remains possible that a lymphoid ganglioside which is distinct from
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brain gangliosides may show specific binding with LPS. Further investigations of the
endogeneous gangliosides of lymphoid populations will be needed to define their
potential role as immunomodulators. Such studies are currently under way in our
laboratory.
It has become evident that investigations on the role of gangliosides in immuno-
modulation will require the isolation and purification of specific gangliosides from
lymphoid cells. Brain gangliosides represent a convenient source for highly purified
gangliosides. They are structurally distinct, however, from the gangliosides found in
lymphoid cells. The most prevalent gangliosides in murine brain are GMI, GDIa, and
GTIb. While it is clear that brain gangliosides may have profound effects on lymphocyte
activation, the physiologic relevance of such observations is open to question. Further
studies should concentrate on defining endogenous gangliosides from appropriate
cellular sources. The inhibitory activities that we and others haveobserved using brain
gangliosides are likely to be nonspecific and secondary to a modulation of the
membrane ofthecell or an interference with the abilityofthe ligand to triggerthe cell.
Further investigations of lymphoid gangliosides and their role in cellular communica-
tion is warranted.
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